Identification and Preliminary Validation in Mouse Models of Circulating Biomarkers of Pancreatic Cancer

Identification and Preliminary Validation in Mouse Models of Circulating Biomarkers of Pancreatic Cancer

Pancreatic ductal adenocarcinoma (PDAC) is one of the most lethal oncological malignancies in humans. Not-specific symptoms and lack of early diagnostic strategies, frequently lead to late diagnosis which limited therapeutic possibilities (Korc, 2007). The present study aimed at identifying novel po...

Full description

Bibliographic Details
Main Authors:	Lucia Minoli, Eugenio Scanziani
Format:	Article
Language:	English
Published:	Università degli Studi di Milano 2018-06-01
Series:	International Journal of Health, Animal Science and Food Safety
Subjects:	Pancreatic cancer Circulating biomarkers KC mice Patient derived xenograft Immunohistochemistry
Online Access:	https://riviste.unimi.it/index.php/haf/article/view/10016

Similar Items

Circulating Tumor Cells as a Biomarker in Pancreatic Ductal Adenocarcinoma
by: Han Liu, et al.
Published: (2017-05-01)

Soluble stroma‐related biomarkers of pancreatic cancer
by: Andrea Resovi, et al.
Published: (2018-08-01)

Circulating Biomarkers for Prediction of Objective Response to Chemotherapy in Pancreatic Cancer Patients
by: Fleur van der Sijde, et al.
Published: (2019-01-01)

Establishment and Characterisation by Expression Microarray of Patient-Derived Xenograft Panel of Human Pancreatic Adenocarcinoma Patients
by: Sandra Roche, et al.
Published: (2020-01-01)

In vivo real-time imaging of gemcitabine-leaded growth inhibition in the orthotopic transplantation model of human pancreatic tumor
by: Sheng-hua Zhang, et al.
Published: (2011-12-01)

Identification of Circulating MiR-25 as a Potential Biomarker for Pancreatic Cancer Diagnosis
by: Ting Deng, et al.
Published: (2016-09-01)

CD26 as a Promising Biomarker for Predicting Prognosis in Patients with Pancreatic Tumors
by: Yan L, et al.
Published: (2020-12-01)

Liquid biopsy in pancreatic ductal adenocarcinoma: current status of circulating tumor cells and circulating tumor DNA
by: Jee‐Soo Lee, et al.
Published: (2019-08-01)

Investigation the Ability to Produce Induced Pluripotent Cells from Human Pancreatic Cancer Xenografts
by: Reyhaneh Khoshchehreh, et al.
Published: (2019-08-01)

GAS2L1 Is a Potential Biomarker of Circulating Tumor Cells in Pancreatic Cancer
by: Lei Zhu, et al.
Published: (2020-12-01)

Enhancing efficacy of gemcitabine in pancreatic patient-derived xenograft mouse models
by: Andriana Inkoom, et al.
Published: (2020-12-01)

Patient-derived xenograft model of well-differentiated pancreatic neuroendocrine tumor in immunodeficient Balb/c Nude mice
by: V. S. Trifanov, et al.
Published: (2020-07-01)

Circulating Tumor Cells in Pancreatic Cancer: Current Perspectives
by: Verena Martini, et al.
Published: (2019-10-01)

Acinar transformed ductal cells exhibit differential mucin expression in a tamoxifen-induced pancreatic ductal adenocarcinoma mouse model
by: Kavita Mallya, et al.
Published: (2020-09-01)

Clinical utility of circulating tumor cells: an update
by: Antoine Vasseur, et al.
Published: (2021-06-01)

Expansion of Circulating Tumor Cells from Patients with Locally Advanced Pancreatic Cancer Enable Patient Derived Xenografts and Functional Studies for Personalized Medicine
by: Lianette Rivera-Báez, et al.
Published: (2020-04-01)

Upcoming Revolutionary Paths in Preclinical Modeling of Pancreatic Adenocarcinoma
by: Mirna Swayden, et al.
Published: (2020-01-01)

AGS cell line xenograft tumor as a suitable gastric adenocarcinoma model: growth kinetic characterization and immunohistochemistry analysis
by: Tahereh Barati, et al.
Published: (2018-07-01)

Circulating microRNAs as promising diagnostic biomarkers for pancreatic cancer: a systematic review
by: Xue J, et al.
Published: (2019-08-01)

Circulating Tumor Cells: Technologies and Their Clinical Potential in Cancer Metastasis
by: Jerry Xiao, et al.
Published: (2021-08-01)

Assessment of Hypoxia in the Stroma of Patient-Derived Pancreatic Tumor Xenografts
by: Ines Lohse, et al.
Published: (2014-02-01)

Advances in pancreatic cancer biomarkers
by: Syed Hasan, et al.
Published: (2019-02-01)

Comparative study on contrast enhancement of Magnevist and Magnevist-loaded nanoparticles in pancreatic cancer PDX model monitored by MRI
by: Kevin Affram, et al.
Published: (2020-05-01)

Biomarkers and cell-based models to predict the outcome of neoadjuvant therapy for rectal cancer patients
by: Aylin Alkan, et al.
Published: (2021-07-01)

Detection of circulating tumor DNA without a tumor-informed search using next-generation sequencing is a prognostic biomarker in pancreatic ductal adenocarcinoma
by: Kajsa E. Affolter, et al.
Published: (2021-09-01)

Tumor Microenvironment In Experimental Models Of Human Cancer: Morphological Investigational Approaches
by: Lucia Minoli, et al.
Published: (2017-05-01)

Immune cell infiltrates as prognostic biomarkers in pancreatic ductal adenocarcinoma: a systematic review and meta‐analysis
by: Andrew J McGuigan, et al.
Published: (2021-03-01)

Aspartate β-hydroxylase promotes pancreatic ductal adenocarcinoma metastasis through activation of SRC signaling pathway
by: Kosuke Ogawa, et al.
Published: (2019-12-01)

Pancreatic Adenocarcinoma Therapeutic Targets Revealed by Tumor-Stroma Cross-Talk Analyses in Patient-Derived Xenografts
by: Rémy Nicolle, et al.
Published: (2017-11-01)

Preclinical Models of Pancreatic Ductal Adenocarcinoma and Their Utility in Immunotherapy Studies
by: Thao N. D. Pham, et al.
Published: (2021-01-01)

HGF/c-Met Inhibition as Adjuvant Therapy Improves Outcomes in an Orthotopic Mouse Model of Pancreatic Cancer
by: Tony C. Y. Pang, et al.
Published: (2021-06-01)

Circulating tumor cell investigation in breast cancer patient-derived xenograft models by automated immunofluorescence staining, image acquisition, and single cell retrieval and analysis
by: Arturo B. Ramirez, et al.
Published: (2019-03-01)

A circulating TH2 cytokines profile predicts survival in patients with resectable pancreatic adenocarcinoma
by: Geny Piro, et al.
Published: (2017-09-01)

Circulating MicroRNAs: Potential Biomarkers for Cancer
by: Yi-Tao Ding, et al.
Published: (2011-03-01)

Global Metabolomics Reveals Urinary Biomarkers of Breast Cancer in a MCF-7 Xenograft Mouse Model
by: Frank J. Gonzalez, et al.
Published: (2013-08-01)

Recent Discoveries of Diagnostic, Prognostic and Predictive Biomarkers for Pancreatic Cancer
by: Andrii Khomiak, et al.
Published: (2020-11-01)

New rat to mouse xenograft transplantation of endometrium as a model of human endometriosis
by: Amir Abdolmaleki, et al.
Published: (2021-09-01)

Predictive biomarkers in chemotherapy of pancreatic duct adenocarcinoma: rewiew of the literature
by: Z A Kovalenko, et al.
Published: (2016-06-01)

CTC-Derived Models: A Window into the Seeding Capacity of Circulating Tumor Cells (CTCs)
by: Tala Tayoun, et al.
Published: (2019-09-01)

Circulating Cell-Free Tumour DNA for Early Detection of Pancreatic Cancer
by: Jedrzej J. Jaworski, et al.
Published: (2020-12-01)

Cannot write session to /tmp/vufind_sessions/sess_dc718o5j9d3e2qhifvlodbl0aa